Xarelto: new oral anticoagulantBayer's Xarelto (rivaroxaban 10 mg tablets) is the second new oral anticoagulant to be marketed in Canada this year, following the introduction of Boehringer Ingelheim's Pradax (dabigatran etexilate 75 mg and 110 mg capsules) in July. Liberals promise catastrophic drug plan Insect repellents: new patient guidelines New Listeria guidelines New Natural Health Products database now available New guidelines: bacterial vaginosis in pregnancy Study finds impact of drug advertising exaggerated Awards predict top sellers Valcyte: new dosage form Shoppers launches new beauty concept First Previous 2185 2186 2187 2188 2189 Next Last
